Skip to content

Feed Screener MCP Methodology

⌘K

EN

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
AMF · FR
BAFIN · DE

Product

Ask the record
Help
Methodology
Signal backtests
Terms
Privacy notice
Object to processing

Language

English Español Français

Feed Screener MCP Methodology

English Español Français

Pricing Sign in

Actavis plc — JUNIPER PHARMACEUTICALS INC insider: 1 transactions · InsiderLens

/ / Actavis plc

Actavis plc

10% owner at JUNIPER PHARMACEUTICALS INC · on record since Mar 12, 2014
10% owner at Furiex Pharmaceuticals, Inc. · on record since Jul 7, 2014
10% owner at Tobira Therapeutics, Inc. · on record since Sep 29, 2016

Insider trading activity of Actavis plc

Transactions on record: 1; since Mar 12, 2014

Open-market buys: 0

Open-market sells: 1; $8.5M

Companies traded: 1; last filing Mar 12, 2014

Figures computed from official regulatory filings — .

Companies where Actavis plc has traded

JUNIPER PHARMACEUTICALS INC1 tx · $8.5M · Mar 12, 2014

Track record of Actavis plc

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Actavis plc

Co-insiders of Actavis plc

Allergan Holdco US, Inc.Tobira Therapeutics, Inc.
Almenoff June SherieFuriex Pharmaceuticals, Inc.
Andrews Valerie LynneJUNIPER PHARMACEUTICALS INC
APOSTOLAKIS JAMES JJUNIPER PHARMACEUTICALS INC
ARMSTRONG FRANK MJUNIPER PHARMACEUTICALS INC
ARTAL GROUP S AFuriex Pharmaceuticals, Inc.
Artal International Management S.A.Furiex Pharmaceuticals, Inc.
ARTAL INTERNATIONAL SCAFuriex Pharmaceuticals, Inc.
BIODISCOVERY 3, FCPRTobira Therapeutics, Inc.
BIOTECHNOLOGY VALUE FUND II LPTobira Therapeutics, Inc.
BIOTECHNOLOGY VALUE FUND L PTobira Therapeutics, Inc.
BLAIR JAMES CTobira Therapeutics, Inc.
BLECHSCHMIDT EDWARD AJUNIPER PHARMACEUTICALS INC
BONDURANT STUARTFuriex Pharmaceuticals, Inc.
Brosgart Carol LTobira Therapeutics, Inc.
BVF INC/ILTobira Therapeutics, Inc.
BVF PARTNERS L P/ILTobira Therapeutics, Inc.
CAMPBELL ANTHONY RJUNIPER PHARMACEUTICALS INC
Catalent, Inc.JUNIPER PHARMACEUTICALS INC
Clark B. JeffersonTobira Therapeutics, Inc.
COLUMBIA LABORATORIES INCJUNIPER PHARMACEUTICALS INC
CONDELLA FRANK JRJUNIPER PHARMACEUTICALS INC
COOGAN MEGJUNIPER PHARMACEUTICALS INC
Cooper Jeffrey HTobira Therapeutics, Inc.
CORR PETER BFuriex Pharmaceuticals, Inc.
Courts ChristopherTobira Therapeutics, Inc.

This page republishes public regulatory disclosures.

COVENTRY ACQUISITION, INC.JUNIPER PHARMACEUTICALS INC

COVINGTON PAUL SFuriex Pharmaceuticals, Inc.

Creasy George William IIJUNIPER PHARMACEUTICALS INC

Crofton James ScottJUNIPER PHARMACEUTICALS INC

Csimma CristinaJUNIPER PHARMACEUTICALS INC

CURRAN JOHN PJUNIPER PHARMACEUTICALS INC

DAVIS STEPHENFuriex Pharmaceuticals, Inc.

DIXON WENDY LFuriex Pharmaceuticals, Inc.

DOMAIN ASSOCIATESTobira Therapeutics, Inc.

DOMAIN PARTERS VII L PTobira Therapeutics, Inc.

Domain Partners VI, L.P.Tobira Therapeutics, Inc.

DOVEY BRIAN HTobira Therapeutics, Inc.

DP VI Associates, L.P.Tobira Therapeutics, Inc.

DP VII ASSOCIATES LPTobira Therapeutics, Inc.

Edmond De Rothschild Investment PartnersTobira Therapeutics, Inc.

Elsey R DonTobira Therapeutics, Inc.

Elston GeorgeJUNIPER PHARMACEUTICALS INC

ESHELMAN FREDRIC NFuriex Pharmaceuticals, Inc.

Fischer LaurentTobira Therapeutics, Inc.

FOREST LABORATORIES INCFuriex Pharmaceuticals, Inc.

Frazier Healthcare V, LPTobira Therapeutics, Inc.

Fromkin Drew JTobira Therapeutics, Inc.

GERAGHTY JAMES AJUNIPER PHARMACEUTICALS INC

Giaquinto Alexander RTobira Therapeutics, Inc.

Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src	Details
JUNIPER PHARMACEUTICALS INCListing unverified	Mar 12, 2014	Sell	-1,400,000	6.08 USD	$8.5M		SEC